Cargando…

Carcinoembryonic Antigen: A Potential Biomarker to Evaluate the Severity and Prognosis of COVID-19

Background and Objectives: Corona Virus Disease 2019 (COVID-19) has become a serious pandemic disease worldwide. Identification of biomarkers to predict severity and prognosis is urgently needed for early medical intervention due to high mortality of critical cases with COVID-19. This retrospective...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Qianqian, Kong, Hui, Qi, Xu, Ding, Wenqiu, Ji, Ningfei, Wu, Chaojie, Huang, Chaolin, Wu, Wenjuan, Huang, Mao, Xie, Weiping, Liu, Yun, Tang, Jinhai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7573292/
https://www.ncbi.nlm.nih.gov/pubmed/33123542
http://dx.doi.org/10.3389/fmed.2020.579543
_version_ 1783597409765425152
author Chen, Qianqian
Kong, Hui
Qi, Xu
Ding, Wenqiu
Ji, Ningfei
Wu, Chaojie
Huang, Chaolin
Wu, Wenjuan
Huang, Mao
Xie, Weiping
Liu, Yun
Tang, Jinhai
author_facet Chen, Qianqian
Kong, Hui
Qi, Xu
Ding, Wenqiu
Ji, Ningfei
Wu, Chaojie
Huang, Chaolin
Wu, Wenjuan
Huang, Mao
Xie, Weiping
Liu, Yun
Tang, Jinhai
author_sort Chen, Qianqian
collection PubMed
description Background and Objectives: Corona Virus Disease 2019 (COVID-19) has become a serious pandemic disease worldwide. Identification of biomarkers to predict severity and prognosis is urgently needed for early medical intervention due to high mortality of critical cases with COVID-19. This retrospective study aimed to indicate the values of carcinoembryonic antigen (CEA) in evaluating the severity and prognosis of COVID-19. Methods: We included 46 death cases from intensive care unit and 68 discharged cases from ordinary units with confirmed COVID-19 of Wuhan Jin Yin-tan Hospital from January 1 to March 22, 2020. Laboratory and radiologic data were analyzed retrospectively. All patients were followed up until April 10, 2020. Results: COVID-19 patients in the death group had significantly higher CEA levels (ng/ml) than discharged group (14.80 ± 14.20 vs. 3.80 ± 2.43, P < 0.001). The risk of COVID-19 death increased 1.317 times for each additional 1 ng/ml CEA level (OR = 1.317, 95% CI: 1.099–1.579). The standardized and weighted receiver operating characteristic curve (ROC) analysis adjusted to age, sex, and ferritin levels suggested that the area under the curve (AUC) of the serum CEA levels was 0.808 in discrimination between death cases and discharged cases with COVID-19 (P < 0.001). We found mortality of COVID-19 is associated with elevated CEA levels increased (HR = 1.023, 95% CI: 1.005–1.042), as well as age (HR = 1.050, 95% CI: 1.016–1.086) and ferritin levels (HR = 1.001, 95% CI: 1.001–1.002) by survival analysis of Cox regression model. Among discharged patients, CEA levels were significant lower in moderate cases compared to the severe and critical cases (P = 0.005; OR = 0.488, 95% CI: 0.294–0.808) from binary logistic regression analysis. The AUC of CEA levels was 0.79 in distinguishing moderate cases from discharged COVID-19 patients by standardized and weighted ROC analysis (P < 0.001). A positive correlation between CEA levels and CT scores existed in discharged patients (Correlation Coefficient: 0.687; P < 0.001). Conclusions: Elevated CEA levels increased the risk of death from COVID-19 and CEA levels were related to CT scores of the discharged patients positively.
format Online
Article
Text
id pubmed-7573292
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-75732922020-10-28 Carcinoembryonic Antigen: A Potential Biomarker to Evaluate the Severity and Prognosis of COVID-19 Chen, Qianqian Kong, Hui Qi, Xu Ding, Wenqiu Ji, Ningfei Wu, Chaojie Huang, Chaolin Wu, Wenjuan Huang, Mao Xie, Weiping Liu, Yun Tang, Jinhai Front Med (Lausanne) Medicine Background and Objectives: Corona Virus Disease 2019 (COVID-19) has become a serious pandemic disease worldwide. Identification of biomarkers to predict severity and prognosis is urgently needed for early medical intervention due to high mortality of critical cases with COVID-19. This retrospective study aimed to indicate the values of carcinoembryonic antigen (CEA) in evaluating the severity and prognosis of COVID-19. Methods: We included 46 death cases from intensive care unit and 68 discharged cases from ordinary units with confirmed COVID-19 of Wuhan Jin Yin-tan Hospital from January 1 to March 22, 2020. Laboratory and radiologic data were analyzed retrospectively. All patients were followed up until April 10, 2020. Results: COVID-19 patients in the death group had significantly higher CEA levels (ng/ml) than discharged group (14.80 ± 14.20 vs. 3.80 ± 2.43, P < 0.001). The risk of COVID-19 death increased 1.317 times for each additional 1 ng/ml CEA level (OR = 1.317, 95% CI: 1.099–1.579). The standardized and weighted receiver operating characteristic curve (ROC) analysis adjusted to age, sex, and ferritin levels suggested that the area under the curve (AUC) of the serum CEA levels was 0.808 in discrimination between death cases and discharged cases with COVID-19 (P < 0.001). We found mortality of COVID-19 is associated with elevated CEA levels increased (HR = 1.023, 95% CI: 1.005–1.042), as well as age (HR = 1.050, 95% CI: 1.016–1.086) and ferritin levels (HR = 1.001, 95% CI: 1.001–1.002) by survival analysis of Cox regression model. Among discharged patients, CEA levels were significant lower in moderate cases compared to the severe and critical cases (P = 0.005; OR = 0.488, 95% CI: 0.294–0.808) from binary logistic regression analysis. The AUC of CEA levels was 0.79 in distinguishing moderate cases from discharged COVID-19 patients by standardized and weighted ROC analysis (P < 0.001). A positive correlation between CEA levels and CT scores existed in discharged patients (Correlation Coefficient: 0.687; P < 0.001). Conclusions: Elevated CEA levels increased the risk of death from COVID-19 and CEA levels were related to CT scores of the discharged patients positively. Frontiers Media S.A. 2020-10-06 /pmc/articles/PMC7573292/ /pubmed/33123542 http://dx.doi.org/10.3389/fmed.2020.579543 Text en Copyright © 2020 Chen, Kong, Qi, Ding, Ji, Wu, Huang, Wu, Huang, Xie, Liu and Tang. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Medicine
Chen, Qianqian
Kong, Hui
Qi, Xu
Ding, Wenqiu
Ji, Ningfei
Wu, Chaojie
Huang, Chaolin
Wu, Wenjuan
Huang, Mao
Xie, Weiping
Liu, Yun
Tang, Jinhai
Carcinoembryonic Antigen: A Potential Biomarker to Evaluate the Severity and Prognosis of COVID-19
title Carcinoembryonic Antigen: A Potential Biomarker to Evaluate the Severity and Prognosis of COVID-19
title_full Carcinoembryonic Antigen: A Potential Biomarker to Evaluate the Severity and Prognosis of COVID-19
title_fullStr Carcinoembryonic Antigen: A Potential Biomarker to Evaluate the Severity and Prognosis of COVID-19
title_full_unstemmed Carcinoembryonic Antigen: A Potential Biomarker to Evaluate the Severity and Prognosis of COVID-19
title_short Carcinoembryonic Antigen: A Potential Biomarker to Evaluate the Severity and Prognosis of COVID-19
title_sort carcinoembryonic antigen: a potential biomarker to evaluate the severity and prognosis of covid-19
topic Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7573292/
https://www.ncbi.nlm.nih.gov/pubmed/33123542
http://dx.doi.org/10.3389/fmed.2020.579543
work_keys_str_mv AT chenqianqian carcinoembryonicantigenapotentialbiomarkertoevaluatetheseverityandprognosisofcovid19
AT konghui carcinoembryonicantigenapotentialbiomarkertoevaluatetheseverityandprognosisofcovid19
AT qixu carcinoembryonicantigenapotentialbiomarkertoevaluatetheseverityandprognosisofcovid19
AT dingwenqiu carcinoembryonicantigenapotentialbiomarkertoevaluatetheseverityandprognosisofcovid19
AT jiningfei carcinoembryonicantigenapotentialbiomarkertoevaluatetheseverityandprognosisofcovid19
AT wuchaojie carcinoembryonicantigenapotentialbiomarkertoevaluatetheseverityandprognosisofcovid19
AT huangchaolin carcinoembryonicantigenapotentialbiomarkertoevaluatetheseverityandprognosisofcovid19
AT wuwenjuan carcinoembryonicantigenapotentialbiomarkertoevaluatetheseverityandprognosisofcovid19
AT huangmao carcinoembryonicantigenapotentialbiomarkertoevaluatetheseverityandprognosisofcovid19
AT xieweiping carcinoembryonicantigenapotentialbiomarkertoevaluatetheseverityandprognosisofcovid19
AT liuyun carcinoembryonicantigenapotentialbiomarkertoevaluatetheseverityandprognosisofcovid19
AT tangjinhai carcinoembryonicantigenapotentialbiomarkertoevaluatetheseverityandprognosisofcovid19